en · de · es · fr · pt
sr9009-notes.peptides6579.com › Blog › Analytical Detection And Regulatory Status — Explained

Analytical Detection And Regulatory Status — Explained

By Editorial Desk · published 2025-09-11 · last reviewed 2025-10-27 · Blog

If you have been reading about LC-MS/MS and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.

Last reviewed on 2025-10-27. Where a claim depends on a specific study, the study is described rather than over-claimed.

Analytical Detection and Regulatory Status

Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.

Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.

Analytical Detection and Stability

Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.

Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.

Sr9009 at a glance

PropertyValueNotes
Regulatory statusNot approved for human useInvestigational status in most countries
Sports statusProhibited by WADAClassified as non-approved or metabolic modulator
Common analytical methodLC-MS/MSUsed for trace detection in biological samples
Typical test matricesUrine and bloodSample choice depends on testing program
Human trial dataNone publishedEffects and safety are not established

Background and Pharmacological Mechanism

SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.

Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.

Related pages on this site

Background and Mechanism

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.

At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.

Further detail

=== Cardiac ventriculography === In cardiac ventriculography, a radionuclide, usually 99mTc, is injected, and the heart is imaged to evaluate the flow through it, to evaluate coronary artery disease, valvular heart disease, congenital heart diseases, cardiomyopathy, and other cardiac disorders. As a nuclear stress test, the average radiation exposure is 9.4 mSv, which when compared with a typical 2 view chest X-ray (.1 mSv) is equivalent to 94 Chest X-Rays. It exposes patients to less radiation than comparable chest X-ray studies.

Proprotein convertases (PPCs) are a family of proteins that activate other proteins. Many proteins are inactive when they are first synthesized, because they contain chains of amino acids that block their activity. Proprotein convertases remove those chains and activate the protein. The prototypical proprotein convertase is furin. Proprotein convertases have medical significance, because they are involved in many important biological processes, such as cholesterol synthesis. Compounds called proprotein convertase inhibitors can block their action, and block the target proteins from becoming active. Many proprotein convertases, especially furin and PACE4, are involved in pathological processes such as viral infection, inflammation, hypercholesterolemia, and cancer, and have been postulated as therapeutic targets for some of these diseases.

Parvocellular oxytocin cells, which project mainly to the brainstem and spinal cord. These neurons are thought to have a role in gastric reflexes and penile erection, Parvocellular vasopressin cells, which project to many points in the hypothalamus and limbic system, as well as to the brainstem and spinal cord (these are involved in blood pressure and temperature regulation), and brown fat thermogenesis. Parvocellular CRH neurons, which are thought to be involved in stress-related behaviors.

Sources: en.wikipedia.org

Supporting material

This contradicts information published earlier in a Wired article, which states that the hyperthymesiac Jill Price had been brain scanned and her "hippocampus and prefrontal cortex were reportedly normal", suggesting that these regions of the brain do not need to be different for hyperthymesia to occur. Significant debate also exists over the limits of memory capacity. Some are of the view that the brain contains so many potential synaptic connections that, in theory at least, no practical limit exists to the number of long-term memories that the brain can store. In 1961, Wilder Penfield reported that specific stimulation of the temporal lobes resulted in vivid recollection of memories. He concluded that our brains were making "continuous, effortless, video-like recordings" of our experiences, but that these records are not consciously accessible to us. However, a study published in the Proceedings of the National Academy of Sciences suggested that hyperthymesiacs may reconstruct memories from traces and incorporate post-event information and associations—a finding at odds with Penfield's video-like recording analogy.

==== 1600–1699 ==== Department of Transport (Fees) (Amendment) Order 1993 (S.I. 1993/1601) Motor Vehicles (Driving Licences) (Amendment) Regulations 1993 (S.I. 1993/1602) Motor Vehicles (Driving Licences) (Large Goods and Passenger-Carrying Vehicles) (Amendment) Regulations 1993 (S.I. 1993/1603) Education (School and Placing Information) (Scotland) Amendment, Etc., Regulations 1993 (S.I. 1993/1604) Education (Provision of Information as to Schools) (Scotland) Regulations 1993 (S.I. 1993/1605) Food Protection (Emergency Prohibitions) (Paralytic Shellfish Poisoning) (No.7) Order 1993 (S.I. 1993/1606) Swanage Light Railway (Extension) Order 1993 (S.I. 1993/1607) Council Tax Limitation (Wales) (Maximum Amount) Order 1993 (S.I. 1993/1608) Further Education (Prescription of Different Date for Property Agreements) (Scotland) Order 1993 (S.I. 1993/1614) Health Boards (Membership and Procedure) (No. 2) Amendment Regulations 1993 (S.I. 1993/1615) Education (Student Loans) (Amendment) Regulations 1993 (S.I. 1993/1620) Community Action (Miscellaneous Provisions) Order 1993 (S.I. 1993/1621) Air Navigation (General) Regulations 1993 (S.I. 1993/1622) Debts of Overseas Governments (Determination of Relevant Percentage) (Amendment) Regulations 1993 (S.I. 1993/1623) Charities (Exemption from Accounting Requirements) (Scotland) Regulations 1993 (S.I. 1993/1624) Right to Purchase (Prescribed Persons) (Scotland) Order 1993 (S.I. 1993/1625) Sheep Annual Premium and Suckler Cow Premium Quotas Regulations 1993 (S.I.

== Sources == Douglas, James Sholto (1975). Hydroponics: The Bengal System: with Notes on Other Methods of Soilless Cultivation. Oxford University Press. ISBN 978-0-19-560530-3. Douglas, James Sholto (1985). Advanced Guide to Hydroponics. Pelham. ISBN 978-0-7207-1571-2. OCLC 1341823405. Jones Jr., J. Benton (2016). Hydroponics. doi:10.1201/9780849331671. ISBN 978-1-4200-3770-8.

Sources: en.wikipedia.org

Frequently asked questions

Is SR9009 approved for human use?

No. It is an investigational compound without approved therapeutic indications. It is sold for research purposes only in many jurisdictions.

Why is SR9009 prohibited in sport?

Sports authorities prohibit it because it is not approved for human use and has potential performance-enhancing effects. It appears on anti-doping lists under non-approved or metabolic modulator categories.

How is SR9009 detected in samples?

Detection usually uses liquid chromatography-tandem mass spectrometry. The method targets the parent compound or its metabolites in urine or blood.

How is SR9009 measured in samples?

The most common approach is liquid chromatography-tandem mass spectrometry, often after extraction from blood, urine, or tissue. Ultraviolet detection and nuclear magnetic resonance spectroscopy are used mainly for reference material characterization. Isotope-labeled internal standards improve accuracy.

Network